MRNA
★★☆☆☆ PassmistralModerna, Inc.
Healthcare · sector percentile 36
세션 움직임
$158.83
거래량 1.78× 평균
44/100 quant · tgt $95.67
ADV$ 3515.1M
세션 2026-08-25 · 스냅샷 — 실시간 호가 아님
직전 스캔 대비
2026-08-24 → 2026-08-25
참고용이며 매수/매도 신호가 아닙니다. 스캔 이력과 캐시된 뉴스·공시로 구성됩니다.
스냅샷 시세
세션 2026-08-25 · 스캔 2026-08-25 · 푸시 08-25 18:33 ET · 애프터아워 (오래됨)
시세 상세 보기시세 상세 숨기기
- 종가/스캔가
- $138.89
- 전일 종가
- $138.89
- 푸시 최신가
- $158.83 (오래됨) · 08-25 18:33 ET · 애프터아워
- 세션 시가
- $143.50
- 직전 세션 범위
- $141.21 – $161.37
- 52주 범위
- $52.66 – $176.66
- 세션 거래량
- 49,046,451
- 평균 거래량 (20일)
- 27,529,103
- 시가총액
- $55.45B
- PER (TTM)
- —
- Forward PER
- -30.32
- 배당 수익률
- 0.00%
- 1년 목표가 추정
- $95.67
- 다음 실적
- —
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. 프리/애프터 시세는 유동성이 얇아 정규장과 다를 수 있습니다.
시장 브리핑
선별된 요약입니다 — 매매 신호가 아닙니다. 헤드라인·링크는 제공된 그대로 표시됩니다.
이 종목의 최근 헤드라인이 없습니다.
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — Moderna’s mRNA pipeline diversification (flu, RSV, cancer vaccines) and strong EPS growth (+21.8% YoY) justify long-term biotech leadership despite near-term volatility.
- Risks — High debt-to-equity (19.0x) and negative ROE (-39%) signal liquidity and profitability risks amid declining COVID-19 vaccine revenue.
- Target Upside — Analyst mean target ($95.67) implies -31% downside from current $138.89, aligning with weak momentum (-1.96% 3M).
Score History
19 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-08-25$138.89−$6.2444.1Pass
- 2026-08-24$145.13+$11.8144.1Pass
- 2026-08-21$133.32−$41.0644.1Pass
- 2026-08-20$174.38+$111.4244.1Pass
- 2026-08-19$62.96−$1.5044.1Pass
- 2026-08-18$64.46+$1.1444.1Pass
- 2026-08-17$63.32−$0.3344.1Pass
- 2026-08-14$63.65+$0.5944.1Pass
- 2026-08-13$63.06+$2.4944.1Pass
- 2026-08-12$60.57+$0.7640.1Pass
- 2026-08-11$59.81+$0.6440.1Pass
- 2026-08-10$59.17+$5.3144.1Pass
- 2026-08-07$53.86−$2.4040.3Pass
- 2026-08-06$56.26−$0.7344.1Pass
- 2026-08-05$56.99+$1.8544.1Pass
- 2026-08-03$55.14+$0.3243.8Pass
- 2026-08-01$54.82−$2.0851.8Pass
- 2026-07-31$56.90−$1.0252.1Pass
- 2026-07-30$57.92—52.1Pass
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 63.8%
- vs 20d (z)
- 1.08
- Short vol
- 17,186,593
- Status
- ok
Squeeze pressure score
full54/100
- Short leg
- 47
- Call leg
- 78
- Activity
- 3.7
- Call vol share
- 72.8%
- PCR (vol)
- 0.37
- Call OI share
- 81.7%
- ATM IV
- 134.0%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
공시 점수 (Disclosure)
캐시된 SEC 공시 기반 News / Insider / Earnings 규칙 다리 — 참고용이며, beat/miss나 매수 신호가 아닙니다.
점수 창에 최근 SEC 공시·실적 일정 입력이 아직 없습니다.
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
실적 서프라이즈 (퀀트 맥락)
최근 퀀트 스캔에 캐시된 Yahoo/공개 펀더멘털 수치입니다 — 공시 이벤트 점수에 합산되지 않으며 매수 신호가 아닙니다. 최신 발표보다 늦을 수 있습니다.
캐시된 지표에 실적 서프라이즈가 없습니다.
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-11-05yahoo_calendar
- Last earnings
- —
- SEC ↗42026-08-07
PRIMARY DOCUMENT
- SEC ↗10-Q2026-07-31
10-Q
- SEC ↗8-K2026-07-31
8-K
- SEC ↗42026-07-16
PRIMARY DOCUMENT
- SEC ↗42026-07-10
PRIMARY DOCUMENT
- SEC ↗8-K2026-07-08
8-K
- SEC ↗42026-07-07
PRIMARY DOCUMENT
- SEC ↗42026-07-06
PRIMARY DOCUMENT
- SEC ↗42026-06-17
PRIMARY DOCUMENT
- SEC ↗42026-06-08
PRIMARY DOCUMENT
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.